Literature DB >> 33331436

RISK FACTORS FOR POST-LIVER TRANSPLANT BILIARY COMPLICATIONS IN THE ABSENCE OF ARTERIAL COMPLICATIONS.

Agnaldo Soares Lima1,2, Bárbara Buitrago Pereira3, Sven Jungmann4, Carla Jorge Machado5, Maria Isabel Toulson Davison Correia1,2.   

Abstract

BACKGROUND: - Biliary complications (BC) represent the most frequent complication after liver transplantation, up to 34% of cases. AIM: To identify modifiable risk factors to biliary complications after liver transplantation, essential to decrease morbidity.
METHOD: Clinical data, anatomical characteristics of recipient and donors, and transplant operation features of 306 transplants with full arterial patency were collected to identify risk factors associated with BC.
RESULTS: BC occurred in 22.9% after 126 days (median) post-transplantation. In univariate analyses group 1 (without BC, n=236) and group 2 patients (with BC, n=70) did not differ on their general characteristics. BC were related to recipient age under 40y (p=0.029), CMV infection (p=0.021), biliary disease as transplant indication (p=0.018), lower pre-transplant INR (p=0.009), and bile duct diameter <3 mm (p=0.033). CMV infections occurred sooner in patients with postoperative biliary complications vs. control (p=0.07). In a multivariate analysis, only CMV infection, lower INR, and shorter bile duct diameter correlated with BC. Positive CMV antigenemia correlated with biliary complications, even when titers lied below the treatment threshold.
CONCLUSIONS: Biliary complications after liver transplantation correlated with low recipient INR before operation, bile duct diameter <3 mm, and positive antigenemia for CMV or disease manifestation. As the only modifiable risk factor, routine preemptive CMV inhibition is suggested to diminish biliary morbidity after liver transplant.

Entities:  

Mesh:

Year:  2020        PMID: 33331436     DOI: 10.1590/0102-672020200003e1541

Source DB:  PubMed          Journal:  Arq Bras Cir Dig        ISSN: 0102-6720


  5 in total

1.  Post-Transplantation Cytomegalovirus Infection Interplays With the Development of Anastomotic Biliary Strictures After Liver Transplantation.

Authors:  Pauline Georges; Clémentine Clerc; Célia Turco; Vincent Di Martino; Brice Paquette; Anne Minello; Paul Calame; Joséphine Magnin; Lucine Vuitton; Delphine Weil-Verhoeven; Zaher Lakkis; Claire Vanlemmens; Marianne Latournerie; Bruno Heyd; Alexandre Doussot
Journal:  Transpl Int       Date:  2022-06-02       Impact factor: 3.842

2.  PRELIMINARY DATA ON LIVER TRANSPLANTATION IN HYDATIDOSIS DISEASE.

Authors:  Alexia Rangel de Castro; Elodie Bomfim Hyppolito; José Telmo Valença-Júnior; Gustavo Rego Coelho; José Huygens Parente Garcia
Journal:  Arq Bras Cir Dig       Date:  2022-06-24

3.  PROTOCOL FOR LIVER TRANSPLANTATION IN HILAR CHOLANGIOCARCINOMA.

Authors:  Lucas Ernani; Rodrigo Bronze de Martino; Wellington Andraus; Eduardo de Souza Martins Fernandes; Felipe Pedreira Tavares de Mello; Ronaldo Andrade; Leandro Savattone Pimentel; Luciana Bertocco de Paiva Haddad; Fabricio Ferreira Coelho; Paulo Herman; Luiz Augusto Carneiro D'Albuquerque
Journal:  Arq Bras Cir Dig       Date:  2022-01-05

4.  BILIARY FISTULAS ASSOCIATED WITH LIVER TRANSPLANTATION VERSUS OTHER ETIOLOGIES: WHAT IS THE SUCCESS RATE OF THE ENDOSCOPIC TREATMENT?

Authors:  Leonardo Marinho; Fred Olavo Andrade Aragão Carneiro; Leonardo José Sales Costa; José Huygens Parente Garcia; Miguel Ângelo Nobre-E-Souza; Marcellus Henrique Loiola Ponte de Souza
Journal:  Arq Bras Cir Dig       Date:  2022-09-16

5.  PROTOCOL FOR LIVER TRANSPLANTATION IN UNRESECTABLE COLORECTAL METASTASIS.

Authors:  Lucas Ernani; Eduardo de Souza Martins Fernandes; Rodrigo Bronze de Martino; Fabricio Ferreira Coelho; Felipe Pedreira Tavares de Mello; Ronaldo Andrade; Leandro Savattone Pimentel; Luciana Bertocco de Paiva Haddad; Paulo Herman; Wellington Andraus; Luiz Augusto Carneiro D'Albuquerque
Journal:  Arq Bras Cir Dig       Date:  2022-01-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.